127 related articles for article (PubMed ID: 24038392)
41. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Guda K; Moinova H; He J; Jamison O; Ravi L; Natale L; Lutterbaugh J; Lawrence E; Lewis S; Willson JK; Lowe JB; Wiesner GL; Parmigiani G; Barnholtz-Sloan J; Dawson DW; Velculescu VE; Kinzler KW; Papadopoulos N; Vogelstein B; Willis J; Gerken TA; Markowitz SD
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12921-5. PubMed ID: 19617566
[TBL] [Abstract][Full Text] [Related]
42. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.
Sprecher E
J Invest Dermatol; 2010 Mar; 130(3):652-60. PubMed ID: 19865099
[TBL] [Abstract][Full Text] [Related]
43. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.
Folsom LJ; Imel EA
Curr Osteoporos Rep; 2015 Apr; 13(2):78-87. PubMed ID: 25656441
[TBL] [Abstract][Full Text] [Related]
44. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ
J Musculoskelet Neuronal Interact; 2007; 7(4):318-9. PubMed ID: 18094491
[No Abstract] [Full Text] [Related]
45. Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis.
Topaz O; Bergman R; Mandel U; Maor G; Goldberg R; Richard G; Sprecher E
Am J Dermatopathol; 2005 Jun; 27(3):211-5. PubMed ID: 15900124
[TBL] [Abstract][Full Text] [Related]
46. Familial tumoral calcinosis: a forty-year follow-up on one family.
Carmichael KD; Bynum JA; Evans EB
J Bone Joint Surg Am; 2009 Mar; 91(3):664-71. PubMed ID: 19255228
[TBL] [Abstract][Full Text] [Related]
47. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ
J Clin Invest; 2007 Sep; 117(9):2684-91. PubMed ID: 17710231
[TBL] [Abstract][Full Text] [Related]
48. Inherited deleterious variants in GALNT12 are associated with CRC susceptibility.
Clarke E; Green RC; Green JS; Mahoney K; Parfrey PS; Younghusband HB; Woods MO
Hum Mutat; 2012 Jul; 33(7):1056-8. PubMed ID: 22461326
[TBL] [Abstract][Full Text] [Related]
49. Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report.
Fabbriciani G; Colombini A; Messina C; Adami G
Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916164
[TBL] [Abstract][Full Text] [Related]
50. A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a
Nishimura-Kinoshita N; Ohata Y; Sawai H; Izawa M; Takeyari S; Kubota T; Omae Y; Ozono K; Tokunaga K; Hamajima T
Clin Pediatr Endocrinol; 2023; 32(3):161-167. PubMed ID: 37362161
[TBL] [Abstract][Full Text] [Related]
51. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
52. Generation of human bronchial epithelial cell lines expressing inactive mutants of GALNT3.
Nakamura S; Horie M; Fujino K; Matsumoto Y; Honda T; Tomonaga K
J Vet Med Sci; 2012 Nov; 74(11):1493-6. PubMed ID: 22785053
[TBL] [Abstract][Full Text] [Related]
53. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
Doss CG; Nagasundaram N
Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
[TBL] [Abstract][Full Text] [Related]
54. High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis.
Ichikawa S; Gray AK; Padgett LR; Reilly AM; Unsicker TR
J Bone Miner Res; 2014 Sep; 29(9):2017-23. PubMed ID: 24692172
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3.
Sahasrabudhe NM; Lenos K; van der Horst JC; RodrÃguez E; van Vliet SJ
Biol Chem; 2018 Jun; 399(7):649-659. PubMed ID: 29894293
[TBL] [Abstract][Full Text] [Related]
56. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
57. Tumoral calcinosis: a dental literature review and case report.
Krstevska A; Gale S; Blair F
Dent Update; 2012; 39(6):416-8, 421. PubMed ID: 22928454
[TBL] [Abstract][Full Text] [Related]
58. Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease.
Guerra MG; Videira T; de Fonseca D; Vieira R; Dos Santos J; Pinto S
Scand J Rheumatol; 2020 Jan; 49(1):80-81. PubMed ID: 31213107
[No Abstract] [Full Text] [Related]
59. A novel homozygous variant in exon 10 of the
Dayal D; Gupta S; Kumar R; Srinivasan R; Lorenz-Depiereux B; Strom TM
Intractable Rare Dis Res; 2021 Feb; 10(1):55-57. PubMed ID: 33614378
[TBL] [Abstract][Full Text] [Related]
60. Prediction of functionally significant single nucleotide polymorphisms in PTEN tumor suppressor gene: An in silico approach.
Khan I; Ansari IA; Singh P; Dass J FP
Biotechnol Appl Biochem; 2017 Sep; 64(5):657-666. PubMed ID: 26800850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]